Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


10.09.2018

1 Ann Afr Med
1 APMIS
1 Biochem Biophys Res Commun
1 BMC Cancer
1 Cancer Res
1 Chin Med J (Engl)
1 Clin Genitourin Cancer
1 Curr Opin Urol
1 Eur J Surg Oncol
1 Eur Urol
2 Eur Urol Focus
1 Int J Cancer
1 J Biomed Res
1 J Natl Compr Canc Netw
1 JAMA Oncol
1 Lasers Med Sci
1 Medicine (Baltimore)
1 Nutr Cancer
1 P R Health Sci J
1 Technol Cancer Res Treat
2 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Afr Med

  1. BOWA K, Mulele C, Kachimba J, Manda E, et al
    A review of bladder cancer in Sub-Saharan Africa: A different disease, with a distinct presentation, assessment, and treatment.
    Ann Afr Med. 2018;17:99-105.
    PubMed     Text format     Abstract available


    APMIS

  2. PIERCONTI F, Martini M, Straccia P, Fiorentino V, et al
    Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma.
    APMIS. 2018;126:705-709.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. WANG F, Zu Y, Huang W, Chen H, et al
    LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
    Biochem Biophys Res Commun. 2018 Aug 31. pii: S0006-291X(18)31844.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. WIJBURG CJ, Michels CTJ, Oddens JR, Grutters JPC, et al
    Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study.
    BMC Cancer. 2018;18:861.
    PubMed     Text format     Abstract available


    Cancer Res


  5. Editor's Note: Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF-kappaB and Upregulation of TRAIL Receptors.
    Cancer Res. 2018;78:5182.
    PubMed     Text format    


    Chin Med J (Engl)

  6. WANG MS, He QB, Yang FY, Ping H, et al
    A Retrospective Study Comparing Surgical and Early Oncological Outcomes between Intracorporeal and Extracorporeal Ileal Conduit after Laparoscopic Radical Cystectomy from a Single Center.
    Chin Med J (Engl). 2018;131:784-789.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  7. FONTEYNE V, Rammant E, Ost P, Lievens Y, et al
    Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium.
    Clin Genitourin Cancer. 2018 Aug 11. pii: S1558-7673(18)30241.
    PubMed     Text format     Abstract available


    Curr Opin Urol

  8. BRUCHBACHER A, Soria F, Hassler M, Shariat SF, et al
    Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?
    Curr Opin Urol. 2018 Sep 3. doi: 10.1097/MOU.0000000000000546.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  9. SIMONE G, Tuderti G, Misuraca L, Anceschi U, et al
    Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series.
    Eur J Surg Oncol. 2018;44:1432-1438.
    PubMed     Text format     Abstract available


    Eur Urol

  10. MOSTAFID H, Palou J, Burger M, Babjuk M, et al
    T1 High-grade Bladder Cancer: The Search for the Optimal Management Continues.
    Eur Urol. 2018 Aug 30. pii: S0302-2838(18)30601.
    PubMed     Text format    


    Eur Urol Focus

  11. CAMPI R, Seisen T, Roupret M
    Unmet Clinical Needs and Future Perspectives in Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2018 Aug 29. pii: S2405-4569(18)30229.
    PubMed     Text format    

  12. TABAYOYONG WB, Kamat AM, O'Donnell MA, McKiernan JM, et al
    Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2018 Sep 3. pii: S2405-4569(18)30238.
    PubMed     Text format     Abstract available


    Int J Cancer

  13. PIAO XM, Jeong P, Kim YH, Byun YJ, et al
    Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31849.
    PubMed     Text format     Abstract available


    J Biomed Res

  14. HASHEMI M, Hasanpour V, Danesh H, Bizhani F, et al
    Association between Pri-miR-34b/c rs4938723 polymorphism and bladder cancer risk.
    J Biomed Res. 2018 Sep 6. doi: 10.7555/JBR.31.20170044.
    PubMed     Text format     Abstract available


    J Natl Compr Canc Netw

  15. FLAIG TW, Spiess PE, Agarwal N, Bangs R, et al
    NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
    J Natl Compr Canc Netw. 2018;16:1041-1053.
    PubMed     Text format     Abstract available


    JAMA Oncol

  16. PEYTON CC, Tang D, Reich RR, Azizi M, et al
    Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer.
    JAMA Oncol. 2018 Aug 30. pii: 2698043. doi: 10.1001/jamaoncol.2018.3542.
    PubMed     Text format     Abstract available


    Lasers Med Sci

  17. LI K, Xu Y, Tan M, Xia S, et al
    A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer.
    Lasers Med Sci. 2018 Aug 31. pii: 10.1007/s10103-018-2604.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  18. ZHU N, Hou J, Wu Y, Liu J, et al
    Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.
    Medicine (Baltimore). 2018;97:e11887.
    PubMed     Text format     Abstract available


    Nutr Cancer

  19. BEN FRADJ MK, Ouanes Y, Hadj-Taieb S, Sallemi A, et al
    Decreased Oleic Acid and Marine n - 3 Polyunsaturated Fatty Acids in Tunisian Patients with Urothelial Bladder Cancer.
    Nutr Cancer. 2018 Sep 5:1-8. doi: 10.1080/01635581.2018.1497668.
    PubMed     Text format     Abstract available


    P R Health Sci J

  20. CHABOWSKI M, Juzwiszyn J, Malinowska K, Kostka A, et al
    The Factors Significantly affecting the Quality of Life of Patients Who undergo Radical Cystectomy due to Bladder Cancer.
    P R Health Sci J. 2018;37:1710.
    PubMed     Text format     Abstract available


    Technol Cancer Res Treat

  21. LIN T, Zhou S, Gao H, Li Y, et al
    MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.
    Technol Cancer Res Treat. 2018;17:1533033818790536.
    PubMed     Text format     Abstract available


    World J Urol

  22. VLACHOSTERGIOS PJ, Faltas BM
    The molecular limitations of biomarker research in bladder cancer.
    World J Urol. 2018 Aug 31. pii: 10.1007/s00345-018-2462.
    PubMed     Text format     Abstract available

  23. HUANG B, Zheng J, Yao Z, Fan W, et al
    Efficacy of intra-arterial chemotherapy combined with intravesical chemotherapy in T1G3 bladder cancer when compared with intravesical chemotherapy alone after bladder-sparing surgery: a retrospective study.
    World J Urol. 2018 Sep 6. pii: 10.1007/s00345-018-2437.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: